Diclofenac induced immune thrombocytopenia.
We describe a patient with scleroderma who developed immune thrombocytopenia secondary to diclofenac on 2 occasions. Platelet count returned to normal with cessation of diclofenac and institution of prednisone.
Epstein
M
M
Department of Medicine, University of British Columbia, St. Paul's Hospital, Vancouver, BC, Canada.
Vickars
L
L
Stein
H
H
D004008:Diclofenac / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007154:Immune System Diseases / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D010976:Platelet Count; D011241:Prednisone / Q000627:therapeutic use; D012595:Scleroderma, Systemic / Q000188:drug therapy; D013921:Thrombocytopenia / Q000097:blood / Q000139:chemically induced* / Q000188:drug therapy
D004008:Diclofenac; D011241:Prednisone